SF 232 – Facility tanning ban for minors
SF 410 – Opioid overdose prevention
HF 372 – Court Appointed Special Advocates & family assessments (companion to SF 370)
FLOOR ACTION:
SF 232, as amended in on the floor, prohibits a tanning facility from allowing a person under 18 to use a tanning device. [3/24: 26-23 (Anderson, Behn, Bertrand, Breitbach, Chapman, Chelgren, Costello, Danielson, Dix, Feenstra, Garrett, Guth, Kapucian, McCoy, Rozenboom, Schultz, Shipley, Sinclair, Smith, Taylor, Whitver, Zaun, Zumbach “no”; Schoenjahn absent)]
SF 410, as amended on the floor, provides immunity from prosecution for the possession, sharing or use of a controlled substance or possession of drug paraphernalia for persons suffering from an opioid overdose, or assisting another person suffering an opioid overdose under these conditions: 1) the reporter calls for medical assistance; 2) the reporter provides his or her name and contact information; 3) the reporter remains on the scene until assistance arrives; and 4) the reporter cooperates with law enforcement and medical personnel.
The bill authorizes the possession of an opioid antagonist if prescribed, dispensed, furnished or otherwise provided by a licensed physician, physician assistant or Advanced Registered Nurse Practitioner, and the person in possession is a family member or friend of, or other person in a position to assist, a person at risk of experiencing an opioid-related overdose. Healthcare professionals are not subject to prosecution or disciplinary action for prescribing antagonists in this context. Emergency medical care providers and law enforcement officers trained in opioid antagonist use and acting in good faith are protected from prosecution or disciplinary action for administering an antagonist.
Those not licensed to prescribe, dispense or administer antagonists may, in an emergency, administer an antagonist if they believe, in good faith, that the other person is suffering an opioid overdose, and are protected from prosecution or disciplinary action. The Department of Public Health will develop standards for recordkeeping and reporting of opioid antagonist use by first responders and will submit an annual report to the Legislature with recommendations. Additionally, the Department will develop protocols and instructions for the administration of opioid antagonists by those who are not health care professionals or first responders. The cost of a prescription opioid antagonist must be covered for employees provided care under workers’ compensation. The Department of Human Services will include an opioid antagonist on the Medicaid preferred drug list, which cannot be subject to prior authorization or utilization management if deemed medically necessary by the prescriber. [3/19: 44-2 (Kinney, Sodders “no”; Bertrand, Chapman, Chelgren, Kapucian absent)]
HF 372 allows court appointed special advocates (CASA) to attend family team meetings or youth transition decision-making meetings upon the request of the family or child. The CASA may disclose case-specific information at those meetings and to the agency assigned by the court to supervise the case, the child’s legal representative or the guardian ad litem. The bill also clarifies which records are confidential. [3/23: 47-0 (Bertrand, Chelgren, Schoenjahn absent)]